CVS Health (NYSE:CVS) Announces Quarterly Earnings Results, Beats Expectations By $0.44 EPS

CVS Health (NYSE:CVS) posted its quarterly earnings results on Wednesday. The pharmacy operator reported $2.09 earnings per share for the quarter, beating the consensus estimate of $1.65 by $0.44, FiscalAI reports. The business had revenue of $108.40 billion during the quarter, compared to analysts’ expectations of $104.72 billion. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. The business’s revenue for the quarter was up 5.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.60 EPS.

Here are the key takeaways from CVS Health’s conference call:

• CVS reported Q3 adjusted EPS of $2.09, up more than 30% year over year, and raised its 2026 adjusted EPS outlook to at least $8.20 and cash flow from operations outlook to at least $15.5 billion.
• Aetna’s adjusted operating income rose to about $900 million, with its medical benefit ratio improving to 91.3%; management said Medicare Advantage is expected to return to profitability in 2026 and deliver further margin improvement in 2027. Pharmacy and Consumer Wellness operating income also rose more than 10%, supported by prescription volume growth.
• CVS expects Health Services adjusted operating income of at least $7 billion in 2027, while identifying declines in 340B and health-plan client membership as headwinds. Management called 2027 a trough year for the segment, with a return to growth expected afterward.
• CVS plans to separate into a health solutions company retaining Aetna, Caremark, specialty pharmacy, and care delivery, and a retail pharmacy and community healthcare company. The tax-free separation is targeted for the first half of 2028; management said both companies should have investment-grade balance sheets and that commercial agreements will preserve key offerings.
• Management set a 2027 adjusted EPS floor of $8.65 and said it expects to reach the high end of its mid-teens adjusted EPS growth range through 2028. The outlook assumes share repurchases offset dilution, but does not include an added contribution from buybacks.

CVS Health Stock Up 3.4%

NYSE:CVS traded up $2.77 during midday trading on Friday, hitting $84.10. 8,656,849 shares of the company were exchanged, compared to its average volume of 8,515,648. The company has a fifty day simple moving average of $90.56 and a 200 day simple moving average of $88.87. CVS Health has a fifty-two week low of $69.51 and a fifty-two week high of $110.68. The company has a current ratio of 0.85, a quick ratio of 0.66 and a debt-to-equity ratio of 0.71. The company has a market capitalization of $107.56 billion, a PE ratio of 9.79, a price-to-earnings-growth ratio of 0.73 and a beta of 0.58.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Investors of record on Thursday, October 22nd were given a $0.6650 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date of this dividend was Thursday, October 22nd. CVS Health’s dividend payout ratio (DPR) is 30.97%.

Analyst Ratings Changes

CVS has been the subject of several recent research reports. JPMorgan Chase & Co. raised their price target on shares of CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th. Jefferies Financial Group reiterated a “buy” rating and issued a $103.00 price objective on shares of CVS Health in a research note on Wednesday. Robert W. Baird set a $107.00 target price on CVS Health in a report on Thursday, August 6th. Piper Sandler set a $112.00 price objective on CVS Health in a research note on Wednesday, September 9th. Finally, Weiss Ratings downgraded CVS Health from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, October 9th. Twenty-two equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $108.25.

Key CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS beat third-quarter earnings and revenue estimates, with revenue up 5.4% year over year. Management raised its 2026 adjusted EPS outlook to at least $8.29 and projected operating cash flow of at least $15.5 billion. CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
• Neutral Sentiment: UBS kept a Buy rating while lowering its price target to $107, indicating continued potential upside in its view but also a more cautious valuation. Tickerreport.com report on UBS price target
• Negative Sentiment: The planned separation by 2028 caught investors off guard. CVS has yet to provide key details on the new companies’ standalone finances, separation costs, debt allocation, or how its dividend would be handled. This lack of clarity appears to have outweighed the earnings beat, and shares dropped sharply after the announcement. CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
• Negative Sentiment: The separation would split retail pharmacies and related services from the health-services business, including Aetna and Caremark. Investors may also be concerned about regulatory pressures and relatively modest expected 2027 growth, while the long timeline leaves room for further changes. CVS to split into two companies

About CVS Health

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division.

The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, the company expanded from a retail pharmacy business into a broad health care organization and adopted the CVS Health name in 2014.